Introduction {#section5-2042098620922480}
============

Adverse drug reactions (ADRs) are '*a response to a medicine which is noxious and unintended, and which occurs at doses normally used in man'.*^[@bibr1-2042098620922480]^ Globally, ADRs are significant cause underlying morbidity and mortality in hospital.^[@bibr2-2042098620922480][@bibr3-2042098620922480]--[@bibr4-2042098620922480]^ The World Health Organization (WHO) has set up a pharmacovigilance (PV) unit and developed a PV strategy to coordinate ADR detection, reporting, and monitoring at a global level, which is managed through the Uppsala Monitoring Center (UMC) based in Sweden.^[@bibr5-2042098620922480]^ PV is defined as 'the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problems'.^[@bibr6-2042098620922480]^ For healthcare organizations and providers, PV is a program to monitor the adverse effects of medications and prevent its occurrence in patients, and to promote patient safety and wellbeing.^[@bibr7-2042098620922480]^ Nepal joined the WHO Pharmacovigilance program in July 2006.^[@bibr8-2042098620922480]^ A National Pharmacovigilance Center was set up at the Department of Drug Administration (DDA) to monitor PV activities in Nepal. Presently, there are 15 regional PV centers in Nepal. As of now, 831 ADR reports have been reported to the National Pharmacovigilance Center at the DDA.^[@bibr9-2042098620922480]^ Several studies have been performed in Nepal on ADRs and PV. Review and analysis of these studies will enhance the understanding of PV in Nepal, and suggest ways to improve PV practice.

As bibliometric analysis measures the quality and impact of research yields,^[@bibr10-2042098620922480]^ it might be helpful to obtain information on ADR reporting and the various activities run by PV centers in Nepal. Evaluation is generally performed by measuring different metrics such as citation counts, H-index, field-weighted citation impact, outputs in top percentiles, journal impact factor, cite score, SCImago journal rank, and Scopus SNIP.^[@bibr11-2042098620922480]^

Only a limited number of bibliometric analyses regarding medication errors and adverse drug events have been carried out. Hung-HC reported a bibliometric analysis of medication errors and adverse drug events studies from 1961 to 2013.^[@bibr12-2042098620922480]^ The database search revealed 3343 and 3342 documentations of medication errors and adverse drug events, respectively. Similarly, utilizing bibliometric visualization techniques, Rodrigues *et al*.^[@bibr13-2042098620922480]^ carried out a study that analyzed the pattern of literature in patient safety that suggests research directions for the future. The latter study showed the frequency of published articles and types of publications regarding PV and ADRs, ^[@bibr14-2042098620922480]^ whereas our present study focuses on the impact of those published papers in different journals.

Bibliometric review is different from systematic review, and is considered a good tool for the evaluation of the pattern and advancement of research activities in a certain field over a period of time utilizing the literature system and available literature in certain area as research objects, and breaking down the literature quantitatively and qualitatively.^[@bibr15-2042098620922480]^ Bibliometric analysis examines bibliographical works within a specific field, theme, institution, or nation-state. It can depict changes and developments in a specific field over a period of time through the analysis of research publications in that field during that given time.^[@bibr16-2042098620922480]^ This can be useful for investigators in assessment of research results, finding gaps, and suggesting that more research be carried out in areas that have not yet been explored, or for future pathways.^[@bibr17-2042098620922480]^

In Nepal, not much information is available on PV research and other activities. One can find studies on PV in Nepal in different Nepalese and international journals. However, no information is available on the nature, pattern, outcomes, and other details of such studies. As a result, the state of PV research, research gaps, and practical recommendations to improve PV practice are lacking. To our knowledge, this is the first effort from the Nepalese pharmacy sector to use a bibliometric approach to explore PV- and ADR-related research activities in Nepal. This bibliometric analysis is important in the field of pharmacy practice since it will provide a comprehensive overview of at current research trends on PV and ADRs in Nepal.

Methods {#section6-2042098620922480}
=======

Study design {#section7-2042098620922480}
------------

This study is a bibliometric review of PV and ADRs in Nepal.

Search strategy and database used {#section8-2042098620922480}
---------------------------------

A systematic search was conducted in PubMed, Web of Science (WoS), Google Scholar, Scopus, and Nepal Journal Online (NepJOL) databases using the search terms 'Adverse Drug Reactions' or 'ADRs' or 'ADR' or 'Adverse drug reaction' or 'AE' or 'Adverse Event' or 'Drug-Induced Reaction' or 'Pharmacovigilance' or 'PV' and 'Nepal'. The search terms included terms describing and covering all fields in PV and ADRs using MeSH terms in PubMed ([Table 1](#table1-2042098620922480){ref-type="table"}) combined with 'Nepal'. A systematic search utilizing both Nepali and English databases was performed. The search covered the period from January 2004 to December 2018 using Medline/PubMed, Index Copernicus, Web of Science, and Scopus. Google and Google Scholar search engines were also used. The Nepalese electronic database included was NepJOL, where 150 journals are listed.

###### 

MeSH keywords (for search in electronic databases both in English).

![](10.1177_2042098620922480-table1)

  --------------------------
  • Adverse Drug reaction\
  • ADRs\
  • ADR Reporting\
  • Adverse Events\
  • AEs\
  • Case report\
  • Drug-Induced\
  • Drug-Induced reaction\
  • Drug Safety\
  • Pharmacovigilance\
  • PV\
  • Reporting

  --------------------------

Inclusion and exclusion criteria {#section9-2042098620922480}
--------------------------------

Different article types, such as original research articles, case reports, review articles, short communications, letters to the editor, brief reports, case series, and education forums by Nepalese authors are included in this study. Articles in the English language, with publication dates between January 2004 and December 2018, relevant to PV and ADRs, and research (or review) based on the Nepalese scenario, were included.

Drug bulletins, articles not published in online journals, online pharmacy newsletters, conference presentations, etc. were excluded. No manual search was performed in libraries of different universities. Papers published in local language were also excluded. We excluded papers published before January 2004 and after December 2018. A flowchart of the operational framework of a bibliometric study is shown in [Figure 1](#fig1-2042098620922480){ref-type="fig"}.

![Flowchart of the operational framework of a bibliometric study.](10.1177_2042098620922480-fig1){#fig1-2042098620922480}

Data collection and validation {#section10-2042098620922480}
------------------------------

On the basis of inclusion and exclusion criteria, two authors independently extracted data from all included publications, including titles, keywords, publication dates, authors, publishing journals, sum of citations, H-index, and so on. The information obtained from the different database were entered in MS-Excel 2010. All the information is again checked and screened by the other two authors. For the validity of the search strategy, two co-authors manually reviewed the 124 articles from the study period.

Data analysis and visualization {#section11-2042098620922480}
-------------------------------

Databases were exported to Excel, and then to IBM SPSS Statistics 26 software package (IBM Corp. Release 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp.). Descriptive analyses of key descriptive study variables were also conducted and are summarized in the tables and figures.

The data exported included:

-   title of journal,

-   title of paper,

-   author's name,

-   number of authors,

-   published year,

-   keywords,

-   journal impact factor (IF),

-   International Standard Serial Number (ISSN), and

-   H-index of the journals

On the basis of the main objectives(s) of the study, articles were classified by two independent reviewers into five categories:

1.  ADRs (incidence, types, prevention and management);

2.  policy and suggestions for strengthening national and regional PV centers of Nepal;

3.  knowledge, attitude, and practice of PV and ADR among healthcare professionals and consumers;

4.  PV and ADR educational interventions among health care professionals and consumers; and

5.  drug withdrawal due to ADRs.

ADR incidence, types, prevention, and management is further divided into domains:

1.  i. Cutaneous adverse drug reactions;

2.  ii. ADRs due to generally prescribed drugs;

3.  iii. ADRs related to antitubercular medicines;

4.  iv. ADRs related to chemotherapy drugs;

5.  v. ADRs due to antihypertensive medicines;

6.  vi. ADRs related neuropsychiatric manifestations;

7.  vii. ADRs due to antileprotic medicines;

8.  viii. ADRs related to antileprotic medicines;

9.  ix. ADRs related to oral hypoglycemic agents;

10. x. ADRs due to anti filarial medicines; and

11. xi. others \[ADRs such as hematological reactions, gastrointestinal (GI) distress\].

Analysis of keywords obtained from all articles included in this study was done using the Word Cloud generator.

Ethical approval {#section12-2042098620922480}
----------------

The data were downloaded from numerous databases such as PubMed, Scopus, and secondary data. The study did not involve any interactions with human subjects or human materials. There were no ethical questions about the data. Approval of an ethics committee was not necessary.

Results {#section13-2042098620922480}
=======

A total of 124 articles were reviewed and analyzed.^[@bibr18-2042098620922480][@bibr19-2042098620922480][@bibr20-2042098620922480][@bibr21-2042098620922480][@bibr22-2042098620922480][@bibr23-2042098620922480][@bibr24-2042098620922480][@bibr25-2042098620922480][@bibr26-2042098620922480][@bibr27-2042098620922480][@bibr28-2042098620922480][@bibr29-2042098620922480][@bibr30-2042098620922480][@bibr31-2042098620922480][@bibr32-2042098620922480][@bibr33-2042098620922480][@bibr34-2042098620922480][@bibr35-2042098620922480][@bibr36-2042098620922480][@bibr37-2042098620922480][@bibr38-2042098620922480][@bibr39-2042098620922480][@bibr40-2042098620922480][@bibr41-2042098620922480][@bibr42-2042098620922480][@bibr43-2042098620922480][@bibr44-2042098620922480][@bibr45-2042098620922480][@bibr46-2042098620922480][@bibr47-2042098620922480][@bibr48-2042098620922480][@bibr49-2042098620922480][@bibr50-2042098620922480][@bibr51-2042098620922480][@bibr52-2042098620922480][@bibr53-2042098620922480][@bibr54-2042098620922480][@bibr55-2042098620922480][@bibr56-2042098620922480][@bibr57-2042098620922480][@bibr58-2042098620922480][@bibr59-2042098620922480][@bibr60-2042098620922480][@bibr61-2042098620922480][@bibr62-2042098620922480][@bibr63-2042098620922480][@bibr64-2042098620922480][@bibr65-2042098620922480][@bibr66-2042098620922480][@bibr67-2042098620922480][@bibr68-2042098620922480][@bibr69-2042098620922480][@bibr70-2042098620922480][@bibr71-2042098620922480][@bibr72-2042098620922480][@bibr73-2042098620922480][@bibr74-2042098620922480][@bibr75-2042098620922480][@bibr76-2042098620922480][@bibr77-2042098620922480][@bibr78-2042098620922480][@bibr79-2042098620922480][@bibr80-2042098620922480][@bibr81-2042098620922480][@bibr82-2042098620922480][@bibr83-2042098620922480][@bibr84-2042098620922480][@bibr85-2042098620922480][@bibr86-2042098620922480][@bibr87-2042098620922480][@bibr88-2042098620922480][@bibr89-2042098620922480][@bibr90-2042098620922480][@bibr91-2042098620922480][@bibr92-2042098620922480][@bibr93-2042098620922480][@bibr94-2042098620922480][@bibr95-2042098620922480][@bibr96-2042098620922480][@bibr97-2042098620922480][@bibr98-2042098620922480][@bibr99-2042098620922480][@bibr100-2042098620922480][@bibr101-2042098620922480][@bibr102-2042098620922480][@bibr103-2042098620922480][@bibr104-2042098620922480][@bibr105-2042098620922480][@bibr106-2042098620922480][@bibr107-2042098620922480][@bibr108-2042098620922480][@bibr109-2042098620922480][@bibr110-2042098620922480][@bibr111-2042098620922480][@bibr112-2042098620922480][@bibr113-2042098620922480][@bibr114-2042098620922480][@bibr115-2042098620922480][@bibr116-2042098620922480][@bibr117-2042098620922480][@bibr118-2042098620922480][@bibr119-2042098620922480][@bibr120-2042098620922480][@bibr121-2042098620922480][@bibr122-2042098620922480][@bibr123-2042098620922480][@bibr124-2042098620922480][@bibr125-2042098620922480][@bibr126-2042098620922480][@bibr127-2042098620922480][@bibr128-2042098620922480][@bibr129-2042098620922480][@bibr130-2042098620922480][@bibr131-2042098620922480][@bibr132-2042098620922480][@bibr133-2042098620922480][@bibr134-2042098620922480][@bibr135-2042098620922480][@bibr136-2042098620922480][@bibr137-2042098620922480][@bibr138-2042098620922480][@bibr139-2042098620922480][@bibr140-2042098620922480][@bibr141-2042098620922480][@bibr142-2042098620922480][@bibr143-2042098620922480]--[@bibr144-2042098620922480]^

Annual number of ADRs and PV publications in Nepal {#section14-2042098620922480}
--------------------------------------------------

[Figure 2](#fig2-2042098620922480){ref-type="fig"} shows the distribution of papers on PV and ADRs by year of publication. Of the articles retrieved, it was found that the years 2006 and 2007 recorded the highest number of publications, that is, 16 publications, whereas in 2004 there were only two publications. The increase in the number of articles published in the period under consideration is shown in [Figure 2](#fig2-2042098620922480){ref-type="fig"}.

![Annual number of ADR and PV publications in Nepal.\
ADR, adverse drug reaction; PV, pharmacovigilance.](10.1177_2042098620922480-fig2){#fig2-2042098620922480}

Average author per article {#section15-2042098620922480}
--------------------------

The average number of authors per paper was 4.10 \[standard deviation (SD) = 1.68\]; 28 papers were authored by 3 authors, whereas 1 paper was written by 10 authors. Only three articles were written by a single author. [Table 2](#table2-2042098620922480){ref-type="table"} lists the average number of authors per article.

###### 

Average number of authors per article.

![](10.1177_2042098620922480-table2)

  Average number of authors   Frequency (*n*)   Percent (%)
  --------------------------- ----------------- -------------
  1                           3                 2.4
  2                           20                16.1
  3                           28                22.6
  4                           24                19.4
  5                           24                19.4
  6                           15                12.1
  7                           7                 5.6
  8                           2                 1.6
  10                          1                 0.8
  Total                       124               100.0

List of journals with frequency of papers published with IF, ISSN, and H-Index {#section16-2042098620922480}
------------------------------------------------------------------------------

The distribution of different journals (*n* = 63) in which the reviewed articles appeared, papers with journal impact factor, and ISSN are listed in [Table 3](#table3-2042098620922480){ref-type="table"}. The highest number of articles were published in the Kathmandu University Medical Journal (KUMJ; 8.0%) followed by the Journal of Institute of Medicine (JIOM; 5.6%). A total of 38 single papers were published in different scientific journals. Online search was performed using Scientific Journal Ranking (SJR) for searching ISSN, H-index number, and SJR factor or impact factor of the journal. For those journals not found on SJR website, the journal homepage containing ISSN and impact factor was considered. Those not found in SJR or journal page were listed as not available (NA).

###### 

List of journals with IF and ISSN.

![](10.1177_2042098620922480-table3)

  Sample number   Name of journal                                                         Frequency   Percent   Journal impact factor/SJR 2017   ISSN                   H-index
  --------------- ----------------------------------------------------------------------- ----------- --------- -------------------------------- ---------------------- ---------
  1               *Acta Dermatovenerol APA*                                               1           0.8       NA                               NA                     NA
  2               *American Journal of Pharmaceutical Education*                          1           0.8       0.62/Q1                          00029459, 15536467     49
  3               *Annals of Pharmacotherapy*                                             1           0.8       1.1/Q1                           15426270, 10600280     100
  4               *Archives of Pharmacy Practice*                                         1           0.8       0.1/Q4                           2045080X               1
  5               *Asia Pacific Allergy*                                                  1           0.8       0.62/Q2                          22338276, 22338268     3
  6               *Asian Journal of Medical Sciences*                                     1           0.8       NA                               2467-9100, 2091-0576   NA
  7               *Australasian Medical Journal*                                          5           4.0       0.32/Q2                          18361935               16
  8               *BMC pharmacology & toxicology*                                         1           0.8       0.78/Q2                          20506511               19
  9               *BMC Research Notes*                                                    1           0.8       0.69/Q2                          17560500               52
  10              *Clinical Pharmacology: Advances and Applications*                      2           1.6       0.97/Q2                          11791438               18
  11              *Dermatology Online Journal*                                            1           0.8       0.33/Q3                          10872108               35
  12              *Drug Information Journal*                                              1           0.8       NA                               NA                     NA
  13              *Drug Safety*                                                           1           0.8       1.45/Q1                          1145916                112
  14              *Health Renaissance*                                                    2           1.6       NA                               1994-7208              NA
  15              *Indian Journal of Psychological Medicine*                              1           0.8       0.37/Q3                          09751564, 02537176     13
  16              *Indian Journal of Pharmacology*                                        1           0.8       0.41/Q3                          19983751, 02537613     49
  17              *International Journal of Basic & Clinical Pharmacology*                1           0.8       NA                               2279-0780              NA
  18              *International Journal of Health Sciences and Research*                 1           0.8       NA                               2249-9571              NA
  19              *International Journal of Pharmaceutical & Biological Archives*         1           0.8       NA                               2581-4303              NA
  20              *International Journal of Pharmacovigilance*                            2           1.6       NA                               2476-2431              NA
  21              *International Journal of Pharmacy*                                     1           0.8       NA                               2249-1848              NA
  22              *International Journal of Risk and Safety in Medicine*                  2           1.6       0.32/Q3                          9246479                19
  23              *Journal of BP Koirala Institute of Health Sciences*                    2           1.6       NA                               2616-0323, 2616-0390   NA
  24              *Journal of Chitwan Medical College*                                    3           2.4       NA                               2091-2412, 2091-2889   NA
  25              *Journal of Clinical and Diagnostic Research*                           7           5.6       0.35/Q3                          0973709X               22
  26              *Journal of College of Medical Sciences-Nepal*                          3           2.4       NA                               2091-065, 2091-0673    NA
  27              *Journal of Gandaki Medical College-Nepal*                              2           1.6       NA                               2070-4240              NA
  28              *Journal of Institute of Medicine*                                      7           5.6       NA                               0259-0972              NA
  29              *Journal of Kathmandu Medical College*                                  1           0.8       NA                               2091-1785, 2091-1793   NA
  30              *Journal of Lumbini Medical College*                                    1           0.8       NA                               2542-2618, 2392-4632   NA
  31              *Journal of Nepal Health Research Council*                              1           0.8       0.15/Q4                          19996217               8
  32              *Journal of Nepal Paediatric Society*                                   1           0.8       0.11/Q4                          19907974, 19907982     6
  33              *Journal of Nepal Pharmaceutical Association*                           1           0.8       NA                               0253-8261              NA
  34              *Journal of Nepalese Society of Periodontology and Oral Implantology*   1           0.8       NA                               2863, 2565-4845        NA
  35              *Journal of Oncology Pharmacy Practice*                                 1           0.8       0.59/Q2                          1477092X, 10781552     26
  36              *Journal of Pakistan Association of Dermatologists*                     6           4.8       0.18/Q3                          15609014               10
  37              *Journal of Pharmacy Practice*                                          1           0.8       0.41/Q3                          8971900                21
  38              *Journal of Pharmacy Practice and Research*                             2           1.6       0.16/Q3                          1445937X               19
  39              *Journal of Psychiatrists' Association of Nepal*                        2           1.6       NA                               2091-2862, 2350-8949   NA
  40              *Journal of Society of Anesthesiologists of Nepal*                      2           1.6       NA                               2362-1281, 2467-9119   NA
  41              *Journal of the Nepal Medical Association*                              2           1.6       0.13/Q4                          282715                 15
  42              *Journal of the Pakistan Medical Association*                           1           0.8       0.28/Q3                          309982                 35
  43              *Kathmandu University Journal of Science, Engineering and Technology*   1           0.8       NA                               1816-8752              NA
  44              *Kathmandu University Medical Journal (KUMJ)*                           10          8.1       0.17/Q3                          18122078, 18122027     20
  45              *Medical Journal of Shree Birendra Hospital*                            1           0.8       NA                               2091-0185, 2091-0193   NA
  46              *Nepal Journal of Dermatology, Venereology & Leprology*                 5           4.0       NA                               2091-0231, 2091-167X   NA
  47              *Nepal Journal of Epidemiology*                                         2           1.6       NA                               2091-0800              NA
  48              *Nepal Journal of Neuroscience*                                         1           0.8       NA                               1813-1948, 1813-1956   NA
  49              *Nepal Journal of Obstetrics and Gynaecology*                           2           1.6       NA                               1999-9623, 1999-8546   NA
  50              *Nepalese Heart Journal*                                                2           1.6       NA                               2091-2978, 2382-5464   NA
  51              *Pakistan Journal of Pharmaceutical Sciences*                           3           2.4       0.36/Q2                          1011601X               33
  52              *Pharmacology online*                                                   4           3.2       0.16/Q4                          18278620               20
  53              *Pharmacy Practice*                                                     3           2.4       0.45/Q2                          1885642X, 18863655     17
  54              *Research in Social and Administrative Pharmacy*                        1           0.8       0.9/Q1                           15517411               33
  55              *SAARC Journal of Tuberculosis, Lung Diseases & HIV/AIDS*               2           1.6       NA                               1818-9741, 2091-0959   NA
  56              *Saudi Pharmaceutical Journal*                                          1           0.8       0.69/Q1                          13190164               30
  57              *Southern Med Review*                                                   1           0.8       NA                               NA                     NA
  58              *The International Journal of Risk and Safety in Medicine*              1           0.8       0.32/Q3                          9246479                19
  59              *The Internet Journal of Dermatology*                                   2           1.6       NA                               1531-2976              NA
  60              *Timisoara Medical Journal*                                             1           0.8       0                                1583526X, 15835251     4
  61              *Tropical Doctor*                                                       1           0.8       0.33/Q3                          494755                 30
  62              *Value in Health*                                                       2           1.6       1.78/Q1                          15244733, 10983015     82
                  Total                                                                   124         100.0                                                             

NA, not available; --, not given.

IF, impact factor; ISSN, international standard serial number; SJR, scientific journal ranking.

Different types of publications recorded {#section17-2042098620922480}
----------------------------------------

Different types of articles were recorded, as shown in [Table 4](#table4-2042098620922480){ref-type="table"}. Brief reports, case reports, education forums, letters to the editor, original research articles, review articles, short communications, and short reports on ADR and PV were published. The number of original research articles published was 52 (41.9%), followed by 39 (31.2%) case reports.

###### 

Type of publications recorded.

![](10.1177_2042098620922480-table4)

  Type of publication         Frequency   Percent
  --------------------------- ----------- ---------
  Original research article   52          41.9
  Case report                 39          31.2
  Review article              12          9.7
  Short communication         10          8.1
  Letter to editor            7           5.6
  Brief report                2           1.6
  Case series                 1           0.8
  Education forum             1           0.8
  Total                       124         100

Research categories and research domains {#section18-2042098620922480}
----------------------------------------

The different types of articles published in different categories and research domains are shown in [Table 5](#table5-2042098620922480){ref-type="table"}. Most (74.1%) research was done in the category of ADRs (incidence, types, prevention and management) followed by policy, and suggestions for strengthening national and regional PV centers of Nepal (14.5%).

###### 

Research categories and research domains.

![](10.1177_2042098620922480-table5)

  Sample number   Category                                                                                                     Research domains   *n*
  --------------- ------------------------------------------------------------------------------------------------------------ ------------------ -------
  1\.             ADRs (incidence, types of therapeutic categories, prevention and management)                                 88                 74.1
                  Cutaneous adverse drug reactions                                                                             33                 37.5
                  ADRs due to generally prescribed drugs                                                                       12                 13.63
                  ADRs related to antitubercular medicines                                                                     11                 12.5
                  ADRs related to chemotherapy drugs                                                                           5                  5.7
                  ADRs due to antihypertensive medicines                                                                       5                  5.7
                  ADRs related neuropsychiatric manifestations                                                                 3                  3.4
                  ADRs due to antileprotic medicines                                                                           2                  2.2
                  ADRs related to oral hypoglycemic agents                                                                     1                  1.1
                  ADRs due to anti filarial medicines                                                                          1                  1.1
                  Others therapeutic categories                                                                                15                 17.0
  2\.             Policy and suggestions for strengthening national and regional pharmacovigilance centers of Nepal            18                 14.5
  3\.             Knowledge, attitude and practice of pharmacovigilance and ADR among healthcare professionals and consumers   6                  4.8
  4\.             Educational intervention health care professionals and consumers pharmacovigilance and ADR among             7                  5.6
  5\.             Drug withdrawal due to ADRs                                                                                  1                  0.8

ADRs, adverse drug reactions.

Analysis of keywords using the Word cloud generator {#section19-2042098620922480}
---------------------------------------------------

The image generated based on the keywords extracted from the articles using Word cloud generator can be seen in [Figure 3](#fig3-2042098620922480){ref-type="fig"}. As an example, keywords like 'adverse drug reactions', 'pharmacovigilance' and 'Nepal' appear larger than other words, demonstrating that they have been mentioned in the articles most commonly.

![Word cloud generator of PV and ADR keywords.\
ADR, adverse drug reaction; PV, pharmacovigilance.](10.1177_2042098620922480-fig3){#fig3-2042098620922480}

Discussion {#section20-2042098620922480}
==========

The results of this study show that 124 articles were published in different journals covering ADR and PV in the Nepalese context. This is the output from the past 15 years, covering 2004 to 2018, and is the first article analyzing the bibliometric of ADR and PV in Nepal.

Only 52 articles were original research articles based on the practice of PV in Nepal. The annual number of publications varied and was skewed over the years, with only two papers in the year 2004 and 16 publications in the year 2006 and 2007. Pattern of ADR reporting, especially to the regional PV centers and teaching hospitals, has been quite consistent.^[@bibr22-2042098620922480],[@bibr94-2042098620922480]^ However, studies on different aspects of ADR and PV have not been carried out in a similar fashion. This may be because not all secondary and tertiary hospitals have PV centers of their own and PV has not received the research focus it should.

Most of the articles were descriptive in nature and were published in Nepalese journals, none of which have an impact factor. Furthermore, some of these journals were also non-indexed. None of the studies involved randomized controlled trials or were interventional studies. It shows that more rigorous studies with sound research designs are required to evaluate the overall state of PV and ADR in Nepal and improve it further.

Analyses of the keywords of these articles showed that the focus of the articles was on PV, ADR, Nepal, consumers, adverse effect, chemotherapy, antibacterial agents, casualty assessment, Naranjo algorithm, etc. The articles were focused on the PV programs and ADR assessment, reporting, ADRs due to antibiotics, chemotherapy and other medicines, and consumer and community involvement in the PV process.

By and large, there is a need to carry out more studies on ADR and PV in Nepal to improve the state of PV and promote quality use of medicines.

Strengths and limitations of this study {#section21-2042098620922480}
---------------------------------------

To the authors' knowledge, this study is the first bibliometric research to assess research activity in the field of PV and ADRs conducted in Nepal. This research highlights trends in drug safety research patterns in Nepal. However, this study has a number of limitations, which need to be listed. First, this study is limited only to research activities of PV and ADRs conducted in the country of Nepal, and PV activities in Nepal are still in their infancy. We have not included drug bulletins or pharmacy newsletters, and we did not perform a manual search of thesis or projects undertaken by undergraduates, graduates, and PhD students in libraries of the different colleges and universities of Nepal. Second, the search strategy used in the current bibliometric study was held to be trustworthy and valid; however, the search strategy probably contained non-negligible errors that cannot be ignored completely. Third, the latest published articles, which were published after December 2018, have not been included in this study. It could have added to the study. Another significant limitation is that the keywords used might not be fully inclusive of possible keywords and there is the possibility of false-positive and false-negative outcomes. Nevertheless, the authors did their best to validate the data by reviewing manually, and tried to make an inclusive assessment of PV and ADRs research productivity in Nepal that ideally will be a positive and progressive expansion to the literature on PV and ADRs.

Take-home messages {#section22-2042098620922480}
------------------

As the significant focus of this study was Nepal only, our future research plan and our recommendations for the scientific community who are interested in ADRs and PV are as follows. First, a need to carry out in-depth systematic reviews of the literature by PV categories, ADR categories, by adverse events categories, by other categories (e.g. drug--drug interactions, medication errors), and by geographical demarcation (e.g. pharmacovigilance and ADR reporting activities within the South Asia or Asia region). Geographical demarcation need not be limited to any specific region; the PV activities of the world can be taken. Second, drug safety is an important area and Nepalese healthcare professionals should be aware of the noxious effects of drugs. Drug regulatory authorities like the DDA as well as consumers also need to be aware of safe drug use. Awareness of drug safety among all stakeholders, such as healthcare providers, regulatory authorities and consumers, aids in early detection and prevention of ADR. Furthermore, studies on different aspects of the ADR process, monitoring and outcomes can provide insights into the state of PV in Nepal and can provide recommendations for further improvements. Third, healthcare professionals and policymakers should focus on PV and ADR reporting so that the national PV system can be improved and the quality use of medicines can be promoted. Fourth, there is an increase in collaborative work in research and it is important to analyze links between scientific researchers in different countries. Further, investments in research should be increased in international research collaborations, and research networks should be encouraged to prioritize research in drug safety. Finally, the results of this study will form a useful baseline to be used by scientific researchers globally. During this bibliographic research, authors could not find articles related to transnational PV with information on new drug safety signals and regulatory actions. Hence, it is important for health professionals and policymakers in each country to enhance PV mechanisms that could potentially benefit regulatory decision making.

Conclusion {#section23-2042098620922480}
==========

This study has summarized research trends in Nepal concerning PV and ADR. It shows that there is a need to study and evaluate ADR and PV in Nepal to improve PV practice and promote quality use of medicines. This study presents a bibliometric overview of publications on PV and ADRs in Nepal through the analysis of temporal research productivity, analysis of types of research papers, and providing a list of journals where these papers are published.
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